Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2007006797) USE OF 4-(3,4-DICHLORO-PHENYL)-1,2,3,4-TETRAHYDRO-NAPHTALEN-1-YLAMINE FOR TREATING CANCER
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2007/006797 International Application No.: PCT/EP2006/064155
Publication Date: 18.01.2007 International Filing Date: 12.07.2006
Chapter 2 Demand Filed: 04.05.2007
IPC:
A61K 31/135 (2006.01) ,A61P 35/00 (2006.01) ,A61P 35/02 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
13
Amines, e.g. amantadine
135
having aromatic rings, e.g. methadone
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35
Antineoplastic agents
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35
Antineoplastic agents
02
specific for leukemia
Applicants:
ANCERIS [FR/FR]; 19 Avenue Du Québec Courtaboeuf 1 F-91140 Villebon Sur Yvette, FR (AllExceptUS)
REVAH, Frédéric [FR/FR]; null (UsOnly)
BALAVOINE, Fabrice [FR/FR]; FR (UsOnly)
TUIJNDER, Marius [NL/BE]; BE (UsOnly)
AMSON, Robert [FR/FR]; null (UsOnly)
TELERMAN, Adam [FR/FR]; null (UsOnly)
Inventors:
REVAH, Frédéric; null
BALAVOINE, Fabrice; FR
TUIJNDER, Marius; BE
AMSON, Robert; null
TELERMAN, Adam; null
Agent:
SCHRIMPF, WARCOIN, AHNER, TEXIER, LE FORESTIER, CALLON DE LAMARCK, COLLIN, TETAZ; Cabinet Regimbeau 20, rue De Chazelles F-75847 Paris Cedex 17, FR
Priority Data:
050748012.07.2005FR
Title (EN) USE OF 4-(3,4-DICHLORO-PHENYL)-1,2,3,4-TETRAHYDRO-NAPHTALEN-1-YLAMINE FOR TREATING CANCER
(FR) UTILISATION DE LA 4-(3,4-DICHLORO-PHENYL)-1,2,3,4-TETRAHYDRO-NAPHTALEN-1-YLAMINE POUR LE TRAITEMENT DU CANCER
Abstract:
(EN) The invention concerns the use of 4-(3,4-dichloro-phenyl)-1,2,3,4-tetrahydro-naphtalen-1-ylamine or any combination of enantiomers thereof or of one it its enantiomers for preparing a pharmaceutical composition for treating cancer, as well as for treating and preventing mestastases.
(FR) Utilisation de la 4-(3,4-dichloro-phényl)-l,2,3,4-tétrahydro-naphtalèn-1-ylamine ou de toute combinaison de ses énantiomères ou d'un de ses énantiomères pour la préparation d'une composition pharmaceutique destinée au traitement du cancer, ainsi qu'au traitement et à la prévention des métastases.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: French (FR)
Filing Language: French (FR)
Also published as:
NO20080722NZ565824MXMX/a/2008/000698APAP/P/2008/004324KR1020080031748IL188685
MA29729VN17873EP1904045ZA2008/00500JP2009501193CN101222917
CA2614696TN2008000010AU2006268657FR2888506ID048.1477